Is Schrodinger, Inc. (SDGR) Halal?

NASDAQ Healthcare United States $818M
✗ NOT HALAL
Confidence: 90/100
Schrodinger, Inc. (SDGR) is Not Halal under AAOIFI Standard 21. While the debt ratio of 11.6% is acceptable, the cash and interest-bearing securities ratio of 42.0% exceeds the 30% threshold. Schrodinger, Inc. operates in the Healthcare sector.

Shariah Screening — 5 Standards

Based on financial data from December 2025

Standard Debt Ratio Cash Ratio Receivables Income Status
AAOIFI 11.6%
/ 30%
42.0%
/ 30%
11.1%
/ 30%
25.24%
/ 5%
✗ NOT HALAL
DJIM 11.6%
/ 33%
42.0%
/ 33%
11.1%
/ 33%
25.24%
/ 5%
✗ NOT HALAL
MSCI 15.0%
/ 33%
54.5%
/ 33%
14.4%
/ 33%
25.24%
/ 5%
✗ NOT HALAL
S&P 11.6%
/ 33%
42.0%
/ 33%
11.1%
/ 33%
25.24%
/ 5%
✗ NOT HALAL
FTSE 15.0%
/ 33%
54.5%
/ 33%
14.4%
/ 50%
25.24%
/ 5%
✗ NOT HALAL

Financial Highlights

EPS
$-1.41
P/B Ratio
2.2
EV/EBITDA
-3.3
EV: $532M
Revenue
$256M
Growth: -1.2%
Beta
1.7
High volatility
Current Ratio
2.7

Profitability

Gross Margin 55.7%
Operating Margin -19.7%
Net Margin -40.4%
Return on Equity (ROE) -26.3%
Return on Assets (ROA) -13.5%

Cash Flow & Balance Sheet

Operating Cash Flow$14M
Free Cash Flow$12M
Total Debt$109M
Debt-to-Equity30.0
Current Ratio2.7
Total Assets$726M

Price & Trading

Last Close$11.57
50-Day MA$13.09
200-Day MA$17.99
Avg Volume1.4M
Beta1.7
52-Week Range
$10.95
$27.63

About Schrodinger, Inc. (SDGR)

CEO
Dr. Ramy Farid Ph.D.
Employees
850
Sector
Healthcare
Industry
Health Information Services
Country
United States
Exchange
NASDAQ
Market Cap
$818M
Currency
USD

Schrödinger, Inc., together with its subsidiaries, develops physics-based computational platform that enables discovery of novel molecules for drug development and materials applications in the United States, the Asia-Pacific, Europe, Middle East, Africa, and internationally. The company operates in two segments, Software and Drug Discovery. The Software segment sells its software to transform molecular discovery for life sciences and materials science industries. The Drug Discovery segment focuses on building a portfolio of preclinical and clinical programs, internally and through collaborations. It has a research collaboration and license agreement with Novartis Pharma AG to advance multiple development candidates. Schrödinger, Inc. was incorporated in 1990 and is based in New York, New York.

Related Halal Stocks in Healthcare

Frequently Asked Questions

Is Schrodinger, Inc. (SDGR) halal to invest in?

Based on our screening using AAOIFI Standard 21 (the strictest methodology), Schrodinger, Inc. is Not Halal. The company fails one or more screening criteria. We screen against all 5 major standards: AAOIFI, DJIM, MSCI, S&P, and FTSE.

What is Schrodinger, Inc.'s debt ratio?

Schrodinger, Inc.'s debt ratio is 11.6% under the AAOIFI standard (which uses market capitalization as the denominator). The AAOIFI threshold is 30%. Under MSCI and FTSE (which use total assets as the denominator), the debt ratio is 15.0%.

What are Schrodinger, Inc.'s key financial metrics?

Schrodinger, Inc. has a market capitalization of $818M, and revenue of $256M. The company maintains a gross margin of 55.7% and a net margin of -40.4%. Return on equity stands at -26.3%.

How often is the screening data updated?

Our screening data is updated regularly using the latest available financial statements and market data. Stock prices and market caps are refreshed frequently, while financial statements are updated quarterly when companies report earnings.

Disclaimer: HalalStockGuide.com provides Shariah compliance screening for educational and informational purposes only. This is not a fatwa, financial advice, or a recommendation to buy or sell any security. Screening results are based on publicly available financial data and established methodologies. Always consult a qualified Islamic scholar and a licensed financial advisor before making investment decisions.